Top Ten Equity Holdings and Exposures

RNS Number : 2692Y
Polar Capital Global Health Tst PLC
07 May 2019
 

7th May 2019

 

Polar Capital Global Healthcare Trust plc (the "Company")

 

Top Ten Equity Holdings and Sector and Geographic Exposure as at 30th April 2019 and full Portfolio listing as at 29th March 2019 available from company's website

 

Polar Capital Global Healthcare Trust plc is pleased to announce that as at 30th April 2019 the top ten equity holdings and the sector and geographic breakdown were as follows:

 

Top 10 Holdings         

%

Johnson & Johnson

8.6%

Abbott Laboratories

5.6%

Merck & Co

5.6%

Alexion Pharmaceuticals

5.0%

Pfizer

4.6%

Takeda Pharmaceutical

4.4%

HCA Holdings

3.9%

Koninklijke Philips

3.8%

Novartis

3.8%

Bio-Rad Laboratories

3.4%

Total

48.8%

 

 

 

Sector Exposure

%

Pharmaceuticals

36.4%

Healthcare Equipment

33.1%

Biotechnology

15.6%

Life Sciences Tools & Services

8.8%

Healthcare Facilities

3.9%

Healthcare Supplies

2.3%

Healthcare Technology

0.6%

Education Services

0.3%

Cash

-0.9%

Total

100.0%

 

 

 

Geographic Exposure

%

United States

65.1%

United Kingdom

11.5%

Japan

5.8%

Netherlands

3.8%

Switzerland

3.8%

Denmark

3.4%

Ireland

3.2%

Spain

3.1%

Italy

0.8%

Sweden

0.3%

Cash

-0.9%

Total

100.0%

 

 

Gearing Ratio as calculated in accordance with the guidelines of the Association of Investment Companies, was 1.2%. Gearing is made up of structural debt provided by the subsidiary company PCGH ZDP plc, through the issue of zero dividend preference shares.

 

 

The monthly factsheet will usually be available on the Company's website on the 10th working day after the month end and includes a commentary by the investment manager.  www.Polarcapitalhealthcaretrust.co.uk

 

Neither the contents of the Company's website nor the contents of any website accessible from the hyperlinks on the Company's website (or any other website) is incorporated into or forms part of this announcement.


This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
PFUUGUWUAUPBGAM
UK 100

Latest directors dealings